To hear about similar clinical trials, please enter your email below
Trial Title:
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
NCT ID:
NCT06070272
Condition:
Recurrent Prostate Cancer
Conditions: Official terms:
Prostatic Neoplasms
Recurrence
Conditions: Keywords:
Recurrent Prostate Cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal
role in evaluating the safety and effectiveness of novel treatments for this condition.
These trials serve as essential tools to determine whether new medications outperform
traditional therapies, providing substantial evidence to endorse their broader
utilization.
It will also try to analyze data from the perspective of different demographic groups to
check for recurring trends which might yield insights for the sake of future patients
with recurrent prostate cancer.
Criteria for eligibility:
Study pop:
Patients with recurrent prostate cancer who are actively considering enrolling in a
clinical study, but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient is at least 18 years of age
- Diagnosis of recurrent prostate cancer
- Ability to understand and the willingness to sign a written informed consent
document
Exclusion Criteria:
- Enrolled in another research study
- Patients with psychiatric illness/social situations that would limit compliance with
study requirements
- Inability to provide written informed consent
Gender:
Male
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
October 2024
Completion date:
October 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06070272
